Haidong Zhu, Gao-Jun Teng, Weijun Fan, Jian-Song Ji, Wei-Zhu Yang, Chang Zhao, Ming Huang, Song Wang, Yu-liang Li, Guo-Liang Shao, Hong-Tao Cheng, Yong-Yi Zeng, Weifu Lv, Hao Xu, Ligong Lu, Hai-Bo Shao, Xu-Ya Zhao, Shan-Zhi Gu, Hai-Lan Lin, Wen-Heng Zheng. "Transarterial chemoembolization (TACE) combined with camrelizumab and apatinib versus TACE alone in the treatment of unresectable hepatocellular carcinoma eligible for embolization: A multicenter, open-label, randomized, phase 2 study (CAP-ACE).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.lba522